Filing Details

Accession Number:
0001593968-25-000043
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-06 21:13:34
Reporting Period:
2025-01-02
Accepted Time:
2025-01-06 21:13:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1824893 Surrozen Inc. SRZN Biological Products, (No Disgnostic Substances) (2836) 301374889
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1990537 Yang Li C/O Surrozen, Inc.
171 Oyster Point Blvd., Suite 400
South San Francisco CA 94080
Exec. Vice President, Research No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-01-02 2,500 $0.00 14,188 No 4 M Direct
Common Stock Disposition 2025-01-03 843 $17.37 13,345 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Footnotes
  1. Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. This transaction represents the settlement of vested RSUs in shares of Issuer's common stock.
  2. Includes 400 shares purchased at a price of $5.67 per share pursuant to the Issuer's 2021 Employee Stock Purchase Plan on December 13, 2024, and 702 shares held through immediate family members of the reporting person.
  3. The shares were sold to cover withholding taxes upon vesting of RSUs in transactions that were initiated by the Issuer on the reporting person's behalf. The price reported reflects the volume-weighted average price for the transactions.